Macrophage inflammatory protein-3alpha plays a key role in the inflammatory cascade in rat focal cerebral ischemia

Neuroscience Research

Volumn 64, Issue 1, 2009, Pages 75-82

  Terao, Yasuko ^a   Ohta, Hiroyuki ^a   Oda, Akira ^a   Nakagaito, Yumiko ^a   Kiyota, Yoshihiro ^a   Shintani, Yasushi ^a  

^a TAKEDA PHARMACEUTICAL COMPANY LIMITED   (Japan)

Author keywords

CC chemokine receptor 6; Cerebral ischemia; Hypothermia; Macrophage inflammatory protein 3 ; Postischemic inflammation; Proinflammatory cytokine

Indexed keywords

CHEMOKINE RECEPTOR CCR6; INTERLEUKIN 1BETA; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA ANTIBODY; MONOCLONAL ANTIBODY; NEUTRALIZING ANTIBODY; NITRIC OXIDE SYNTHASE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BRAIN INFARCTION; BRAIN ISCHEMIA; CONTROLLED STUDY; GENE EXPRESSION; MALE; MICROGLIA; MIDDLE CEREBRAL ARTERY OCCLUSION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR UPREGULATION; UPREGULATION;

ANIMALS; ANTIBODIES; ASTROCYTES; BRAIN; CELLS, CULTURED; CHEMOKINE CCL20; CYTOKINES; HYPOTHERMIA; INFARCTION, MIDDLE CEREBRAL ARTERY; INTERLEUKIN-1BETA; MALE; MICROGLIA; NITRIC OXIDE SYNTHASE TYPE II; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CCR1; RECEPTORS, CCR2; RECEPTORS, CCR6; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA;

EID: 64249155625     PISSN: 01680102     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neures.2009.01.017     Document Type: Article

References (43)

1. Ambrosini E., Columba-Cabezas S., Serafini B., Muscella A., and Aloisi F. Astrocytes are the major intracerebral source of macrophage inflammatory protein-3alpha/CCL20 in relapsing experimental autoimmune encephalomyelitis and in vitro. Glia 41 (2003) 290-300
2. Barone F.C., Hillegass L.M., Price W.J., White R.F., Lee E.V., Feuerstein G.Z., Sarau H.M., Clark R.K., and Griswold D.E. Polymorphonuclear leukocyte infiltration into cerebral focal ischemic tissue: myeloperoxidase activity assay and histologic verification. J. Neurosci. Res. 29 (1991) 336-345
3. Bernard S.A., Gray T.W., Buist M.D., Jones B.M., Silvester W., Gutteridge G., and Smith K. Treatment of comatose survivors of out-of-hospital cardiac arrest with induced hypothermia. N. Engl. J. Med. 346 (2002) 557-563
4. Bracke K.R., D'hulst A.I., Maes T., Moerloose K.B., Demedts I.K., Lebecque S., Joos G.F., and Brusselle G.G. Cigarette smoke-induced pulmonary inflammation and emphysema are attenuated in CCR6-deficient mice. J. Immunol. 177 (2006) 4350-4359
5. Campbell J.J., Hedrick J., Zlotnik A., Siani M.A., Thompson D.A., and Butcher E.C. Chemokines and the arrest of lymphocytes rolling under flow conditions. Science 279 (1998) 381-384
6. Charbonnier A.S., Kohrgruber N., Kriehuber E., Stingl G., Rot A., and Maurer D. Macrophage inflammatory protein 3alpha is involved in the constitutive trafficking of epidermal langerhans cells. J. Exp. Med. 190 (1999) 1755-1768
7. Chan P.H. Reactive oxygen radicals in signaling and damage in the ischemic brain. J. Cereb. Blood Flow Metab. 21 (2001) 2-14
8. Cook D.N., Prosser D.M., Forster R., Zhang J., Kuklin N.A., Abbondanzo S.J., Niu X.D., Chen S.C., Manfra D.J., Wiekowski M.T., Sullivan L.M., Smith S.R., Greenberg H.B., Narula S.K., Lipp M., and Lira S.A. CCR6 mediates dendritic cell localization, lymphocyte homeostasis, and immune responses in mucosal tissue. Immunity 12 (2000) 495-503
9. Crittenden M., Gough M., Harrington K., Olivier K., Thompson J., and Vile R.G. Expression of inflammatory chemokines combined with local tumor destruction enhances tumor regression and long-term immunity. Cancer Res. 63 (2003) 5505-5512
10. de Haas A.H., van Weering H.R., de Jong E.K., Boddeke H.W., and Biber K.P. Neuronal chemokines: versatile messengers in central nervous system cell interaction. Mol. Neurobiol. 36 (2007) 137-151
11. Dieu M.C., Vanbervliet B., Vicari A., Bridon J.M., Oldham E., Ait-Yahia S., Briere F., Zlotnik A., Lebecque S., and Caux C. Selective recruitment of immature and mature dendritic cells by distinct chemokines expressed in different anatomic sites. J. Exp. Med. 188 (1998) 373-386
12. Dimitrijevic O.B., Stamatovic S.M., Keep R.F., and Andjelkovic A.V. Effects of the chemokine CCL2 on blood-brain barrier permeability during ischemia-reperfusion injury. J. Cereb. Blood Flow Metab. 26 (2006) 797-810
13. Dimitrijevic O.B., Stamatovic S.M., Keep R.F., and Andjelkovic A.V. Absence of the chemokine receptor CCR2 protects against cerebral ischemia/reperfusion injury in mice. Stroke 38 (2007) 1345-1353
14. Flynn G., Maru S., Loughlin J., Romero I.A., and Male D. Regulation of chemokine receptor expression in human microglia and astrocytes. J. Neuroimmunol. 136 (2003) 84-93
15. Furuichi Y., Noto T., Li J.Y., Oku T., Ishiye M., Moriguchi A., Aramori I., Matsuoka N., Mutoh S., and Yanagihara T. Multiple modes of action of tacrolimus (FK506) for neuroprotective action on ischemic damage after transient focal cerebral ischemia in rats. Brain Res. 1014 (2004) 120-130
16. Han H.S., Karabiyikoglu M., Kelly S., Sobel R.A., and Yenari M.A. Mild hypothermia inhibits nuclear factor-kappaB translocation in experimental stroke. J. Cereb. Blood Flow Metab. 23 (2003) 589-598
17. Homey B., Dieu-Nosjean M.C., Wiesenborn A., Massacrier C., Pin J.J., Oldham E., Catron D., Buchanan M.E., Muller A., de Waal Malefyt R., Deng G., Orozco R., Ruzicka T., Lehmann P., Lebecque S., Caux C., and Zlotnik A. Up-regulation of macrophage inflammatory protein-3 alpha/CCL20 and CC chemokine receptor 6 in psoriasis. J. Immunol. 164 (2000) 6621-6632
18. Kaser A., Ludwiczek O., Holzmann S., Moschen A.R., Weiss G., Enrich B., Graziadei I., Dunzendorfer S., Wiedermann C.J., Murzl E., Grasl E., Jasarevic Z., Romani N., Offner F.A., and Tilg H. Increased expression of CCL20 in human inflammatory bowel disease. J. Clin. Immunol. 24 (2004) 74-85
19. Katchar K., Kelly C.P., Keates S., O'brien M.J., and Keates A.C. MIP-3alpha neutralizing monoclonal antibody protects against TNBS-induced colonic injury and inflammation in mice. Am. J. Physiol. Gastrointest. Liver Physiol. 292 (2007) G1263-1271
20. Kawai N., Okauchi M., Morisaki K., and Nagao S. Effects of delayed intraischemic and post-ischemic hypothermia on a focal model of transient cerebral ischemia in rats. Stroke 31 (2000) 1982-1989
21. Kil H.Y., Zhang J., and Piantadosi C.A. Brain temperature alters hydroxyl radical production during cerebral ischemia/reperfusion in rats. J. Cereb. Blood Flow Metab. 16 (1996) 100-106
22. Kleeff J., Kusama T., Rossi D.L., Ishiwata T., Maruyama H., Friess H., Buchler M.W., Zlotnik A., and Korc M. Detection and localization of Mip-3alpha/LARC/Exodus, a macrophage proinflammatory chemokine, and its CCR6 receptor in human pancreatic cancer. Int. J. Cancer 81 (1999) 650-657
23. Lu X.C., Williams A.J., Yao C., Berti R., Hartings J.A., Whipple R., Vahey M.T., Polavarapu R.G., Woller K.L., Tortella F.C., and Dave J.R. Microarray analysis of acute and delayed gene expression profile in rats after focal ischemic brain injury and reperfusion. J. Neurosci. Res. 77 (2004) 843-857
24. Matsuo Y., Onodera H., Shiga Y., Shozuhara H., Ninomiya M., Kihara T., Tamatani T., Miyasaka M., and Kogure K. Role of cell adhesion molecules in brain injury after transient middle cerebral artery occlusion in the rat. Brain Res. 656 (1994) 344-352
25. Merad M., Hoffmann P., Ranheim E., Slaymaker S., Manz M.G., Lira S.A., Charo I., Cook D.N., Weissman I.L., Strober S., and Engleman E.G. Depletion of host Langerhans cells before transplantation of donor alloreactive T cells prevents skin graft-versus-host disease. Nat. Med. 10 (2004) 510-517
26. Middel P., Raddatz D., Gunawan B., Haller F., and Radzun H.J. Increased number of mature dendritic cells in Crohn's disease: evidence for a chemokine mediated retention mechanism. Gut 55 (2006) 220-227
27. Miyazawa T., Tamura A., Fukui S., and Hossmann K.A. Effect of mild hypothermia on focal cerebral ischemia. Review of experimental studies. Neurol. Res. 25 (2003) 457-464
28. Nakka V.P., Gusain A., Mehta S.L., and Raghubir R. Molecular mechanisms of apoptosis in cerebral ischemia: multiple neuroprotective opportunities. Mol. Neurobiol. 37 (2008) 7-38
29. Ohta H., Terao Y., Shintani Y., and Kiyota Y. Therapeutic time window of post-ischemic mild hypothermia and the gene expression associated with the neuroprotection in rat focal cerebral ischemia. Neurosci. Res. 57 (2007) 424-433
30. Perez-Canadillas J.M., Zaballos A., Gutierrez J., Varona R., Roncal F., Albar J.P., Marquez G., and Bruix M. NMR solution structure of murine CCL20/MIP-3alpha, a chemokine that specifically chemoattracts immature dendritic cells and lymphocytes through its highly specific interaction with the beta-chemokine receptor CCR6. J. Biol. Chem. 276 (2001) 28372-28379
31. Rostène W., Kitabgi P., and Parsadaniantz S.M. Chemokines: a new class of neuromodulator?. Nat. Rev. Neurosci. 8 (2007) 895-903
32. Schousboe A., Fosmark H., and Hertz L. High content of glutamate and of ATP in astrocytes cultured from rat brain hemispheres: effect of serum withdrawal and of cyclic AMP. J. Neurochem. 25 (1975) 909-911
33. Schutyser E., Struyf S., and Van Damme J. The CC chemokine CCL20 and its receptor CCR6. Cytokine Growth Factor Rev. 14 (2003) 409-426
34. Serafini B., Columba-Cabezas S., Di Rosa F., and Aloisi F. Intracerebral recruitment and maturation of dendritic cells in the onset and progression of experimental autoimmune encephalomyelitis. Am. J. Pathol. 157 (2000) 1991-2002
35. Shimohata T., Zhao H., and Steinberg G.K. Epsilon PKC may contribute to the protective effect of hypothermia in a rat focal cerebral ischemia model. Stroke 38 (2007) 375-380
36. Utans-Schneitz U., Lorez H., Klinkert W.E., Da Silva J., and Lesslauer W. A Novel rat CC chemokine, identified by targeted differential display, is upregulated in brain inflammation. J. Neuroimmunol. 92 (1998) 179-190
37. Wang G.J., Deng H.Y., Maier C.M., Sun G.H., and Yenari M.A. Mild hypothermia reduces ICAM-1 expression, neutrophil infiltration and microglia/monocyte accumulation following experimental stroke. Neuroscience 114 (2002) 1081-1090
38. Wood P.L. Microglia as a unique cellular target in the treatment of stroke: potential neurotoxic mediators produced by activated microglia. Neurol. Res. 17 (1995) 242-248
39. Yamashiro S., Wang J.M., Yang D., Gong W.H., Kamohara H., and Yoshimura T. Expression of CCR6 and CD83 by cytokine-activated human neutrophils. Blood 96 (2000) 3958-3963
40. Yanamoto H., Nagata I., Niitsu Y., Zhang Z., Xue J.H., Sakai N., and Kikuchi H. Prolonged mild hypothermia therapy protects the brain against permanent focal ischemia. Stroke 32 (2001) 232-239
41. Yenari M.A., Iwayama S., Cheng D., Sun G.H., Fujimura M., Morita-Fujimura Y., Chan P.H., and Steinberg G.K. Mild hypothermia attenuates cytochrome c release but does not alter Bcl-2 expression or caspase activation after experimental stroke. J. Cereb. Blood Flow Metab. 22 (2002) 29-38
42. Zheng Z., and Yenari M.A. Post-ischemic inflammation: molecular mechanisms and therapeutic implications. Neurol. Res. 26 (2004) 884-892
43. Zoli M., Grimaldi R., Ferrari R., Zini I., and Agnati L.F. Short- and long-term changes in striatal neurons and astroglia after transient forebrain ischemia in rats. Stroke 28 (1997) 1049-1059